Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1971 May;42(1):137-42.
doi: 10.1111/j.1476-5381.1971.tb07093.x.

Specificity of some ganglion stimulants

Specificity of some ganglion stimulants

R B Barlow et al. Br J Pharmacol. 1971 May.

Abstract

1. The specificity of several ganglion stimulants has been tested on the isolated guinea-pig ileum by measuring the dose ratios produced by concentrations of hexamethonium.2. Most ganglion stimulants are also active at postganglionic receptors, some as blocking agents (for example, lobeline and dimethylphenylpiperazinium), others as agonists (for example, o-aminophenethyltrimethylammonium and, to a lesser extent, nicotine). The most specific ganglion stimulant, with the least activity at postganglionic receptors, was p-aminophenethyltrimethylammonium.3. The affinity constants of lobeline and dimethylphenylpiperazinium for the muscarine sensitive receptors in the guinea-pig ileum are 1.05 x 10(6) and 3.71 x 10(4), respectively.4. The antagonism of p-aminophenethyltrimethylammonium by hexamethonium gave results consistent with competition up to dose ratios of about 20. Such results could also be obtained if the antagonism were non-competitive, however, provided large responses could be obtained with less than about 5% of the receptors in the ganglia activated. The affinity constant of hexamethonium is about 2.6 x 10(5).5. It is suggested that the affinity of hexamethonium can largely be ascribed to hydrophobic bonding.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1969 Sep;37(1):207-33 - PubMed
    1. Br J Pharmacol. 1969 Nov;37(3):555-84 - PubMed
    1. J Physiol. 1890 Jan;11(1-2):123-158.1 - PubMed
    1. Br J Pharmacol Chemother. 1966 Aug;27(2):286-98 - PubMed
    1. J Pharmacol Exp Ther. 1951 Nov;103(3):330-6 - PubMed

LinkOut - more resources